SLEEP, vol.40, no.11, 2017 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED), Scopus
continuous positive airway pressure, coronary artery disease, obstructive sleep apnea, interleukin-6, interleukin-8, tumor necrosis factor-alpha, C-REACTIVE PROTEIN, POSITIVE AIRWAY PRESSURE, CARDIOVASCULAR RISK-FACTORS, INTERLEUKIN-6, EVENTS, PREDICTORS, THERAPY, MARKERS
Süleyman Demirel University Affiliated:
Objectives: Obstructive sleep apnea (OSA) and enhanced vascular inflammation coexist in patients with coronary artery disease (CAD). Continuous positive airway pressure (CPAP) is first-line treatment for OSA with daytime sleepiness. This analysis of data from the RICCADSA (Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnea) trial investigated the effects of CPAP on inflammatory markers in patients with CAD and nonsleepy OSA.